Related Experiment Videos
[Metapramine: antidepressant and psycho-stimulant]
L'Encephale
|January 1, 1976
Summary
Metapramine, a novel tricyclic antidepressant, offers both mood-lifting and psychostimulating effects. Its unique no-anticholinergic action contributes to high patient tolerance, making it a promising new treatment option.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Context:
- Antidepressant drug development
- Treatment of mood disorders
- Tricyclic compounds
Purpose:
- Introduce metapramine, a novel antidepressant.
- Highlight its unique pharmacological profile.
- Discuss its therapeutic potential.
Summary:
- Metapramine is a novel tricyclic antidepressant with dual thymoanaleptic and psychostimulating properties.
- Its unique molecular structure confers a distinct activity profile.
- A key feature is its high tolerance, potentially linked to a lack of anticholinergic effects.
Impact:
- Metapramine represents a potentially significant advancement in antidepressant therapy.
- Its favorable side-effect profile may improve patient compliance and outcomes.
- Further research could establish metapramine as a valuable tool in managing depression.